The development and SAR of pyrrolidine carboxamide 11β-HSD1 inhibitors
摘要:
The design and development of a series of highly selective pyrrolidine carboxamide 11 beta-HSD1 inhibitors are described. These compounds including PF-877423 demonstrated potent in vitro activity against both human and mouse 11 beta-HSD1 enzymes. In an in vivo assay, PF-877423 inhibited the conversion of cortisone to cortisol. Structure guided optimization effort yielded potent and stable 11 beta-HSD1 selective inhibitor 42. (C) 2010 Elsevier Ltd. All rights reserved.
The development and SAR of pyrrolidine carboxamide 11β-HSD1 inhibitors
摘要:
The design and development of a series of highly selective pyrrolidine carboxamide 11 beta-HSD1 inhibitors are described. These compounds including PF-877423 demonstrated potent in vitro activity against both human and mouse 11 beta-HSD1 enzymes. In an in vivo assay, PF-877423 inhibited the conversion of cortisone to cortisol. Structure guided optimization effort yielded potent and stable 11 beta-HSD1 selective inhibitor 42. (C) 2010 Elsevier Ltd. All rights reserved.
The design and development of a series of highly selective pyrrolidine carboxamide 11 beta-HSD1 inhibitors are described. These compounds including PF-877423 demonstrated potent in vitro activity against both human and mouse 11 beta-HSD1 enzymes. In an in vivo assay, PF-877423 inhibited the conversion of cortisone to cortisol. Structure guided optimization effort yielded potent and stable 11 beta-HSD1 selective inhibitor 42. (C) 2010 Elsevier Ltd. All rights reserved.